Open AccessA Randomized, Double-Blind, Pilot Study of the Effect of Famotidine on Acotiamide Treatment for Functional Dyspepsia
Author(s) -
Mariko Hojo,
Akihito Nagahara,
Daisuke Asaoka,
Tsutomu Takeda,
Kiyotaka Izumi,
Keīichi Matsumoto,
Hiroya Ueyama,
Yuji Shimada,
Kenshi Matsumoto,
Shuko Nojiri,
Sumio Watanabe
Publication year - 2017
Publication title -
digestion
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.882
H-Index - 75
eISSN - 1421-9867
pISSN - 0012-2823
DOI - 10.1159/000477345
Subject(s) - famotidine , medicine , placebo , gastroenterology , pathology , alternative medicine
Acotiamide, a prokinetic drug, is used to treat functional dyspepsia (FD), especially postprandial distress syndrome (PDS). However, a treatment for FD patients with PDS and/or epigastric pain syndrome (EPS) has not been established. We investigated the efficacy of famotidine in combination with acotiamide for FD.